Publications by authors named "R Scott Struthers"

Claim this Profile
R
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-Daily Oral Paltusotine Treatment.
Beverly M K Biller, Alessandra Casagrande, Atanaska Elenkova, Cesar L Boguszewski, Raquel S Jallad, R Scott Struthers

J Clin Endocrinol Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants.
Rosa Luo, Ajay Madan, Christine T Ferrara-Cook, Deepak Dalvie, Lance Goulet, R Scott Struthers

Br J Clin Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.
Mônica R Gadelha, Alessandra Casagrande, Christian J Strasburger, Martin Bidlingmaier, Peter J Snyder, R Scott Struthers

J Clin Endocrinol Metab· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist.
Sun Hee Kim, Sangdon Han, Jian Zhao, Shimiao Wang, Ana Karin Kusnetzow, R Scott Struthers

ACS Med Chem Lett· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist.
Jian Zhao, Shimiao Wang, Stacy Markison, Sun Hee Kim, Sangdon Han, R Scott Struthers

ACS Med Chem Lett· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis